639 related articles for article (PubMed ID: 33952670)
1. Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial.
Wang Y; Johnston C; Bath PM; Meng X; Jing J; Xie X; Wang A; Pan Y; Xu A; Dong Q; Wang Y; Zhao X; Li Z; Li H;
Stroke Vasc Neurol; 2021 Jun; 6(2):280-285. PubMed ID: 33952670
[TBL] [Abstract][Full Text] [Related]
2. One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in
Meng X; Wang A; Tian X; Johnston C; Li H; Bath PM; Xu Q; Zhang Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang Y
Neurology; 2024 Feb; 102(3):e207809. PubMed ID: 38181311
[TBL] [Abstract][Full Text] [Related]
3. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor Aspirin vs Clopidogrel Aspirin in
Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y
Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y;
BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523
[TBL] [Abstract][Full Text] [Related]
6. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
[TBL] [Abstract][Full Text] [Related]
7. Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction.
Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
Neurology; 2023 Apr; 100(16):e1643-e1654. PubMed ID: 36697242
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES).
Gao Y; Pan Y; Han S; Chen W; Jing J; Wang C; Yang Y; Wang T; Meng X; Zhao X; Liu L; Li H; Johnston SC; Amarenco P; Bath PM; Wang Y; Wang Y;
Stroke Vasc Neurol; 2023 Jun; 8(3):249-258. PubMed ID: 36707080
[TBL] [Abstract][Full Text] [Related]
9. Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in
Wang A; Tian X; Xie X; Li H; Jing J; Lin J; Wang Y; Zhao X; Li Z; Liu L; Wang Y; Meng X
EClinicalMedicine; 2024 Jan; 67():102357. PubMed ID: 38125963
[TBL] [Abstract][Full Text] [Related]
10. Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack.
Zhang J; Wang A; Tian X; Meng X; Xie X; Jing J; Lin J; Wang Y; Li Z; Liu L; Li H; Jiang Y; Zhao X; Wang Y
CMAJ; 2023 Jul; 195(26):E897-E904. PubMed ID: 37429630
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor versus Clopidogrel in
Wang Y; Meng X; Wang A; Xie X; Pan Y; Johnston SC; Li H; Bath PM; Dong Q; Xu A; Jing J; Lin J; Niu S; Wang Y; Zhao X; Li Z; Jiang Y; Li W; Liu L; Xu J; Chang L; Wang L; Zhuang X; Zhao J; Feng Y; Man H; Li G; Wang B;
N Engl J Med; 2021 Dec; 385(27):2520-2530. PubMed ID: 34708996
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by
Zhou M; Chen W; Pan Y; Lin Y; Meng X; Zhao X; Liu L; Lin J; Li H; Wang Y; Wang Y
Aging (Albany NY); 2020 Dec; 13(3):3994-4006. PubMed ID: 33411687
[TBL] [Abstract][Full Text] [Related]
13. Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial.
Zhang XG; Zhu XQ; Xue J; Li ZZ; Jiang HY; Hu L; Yue YH
BMJ Open; 2019 May; 9(5):e028595. PubMed ID: 31123001
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA.
Yang Y; Chen W; Pan Y; Yan H; Meng X; Liu L; Wang Y; Wang Y
Front Neurol; 2020; 11():534. PubMed ID: 32587571
[No Abstract] [Full Text] [Related]
15. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
[TBL] [Abstract][Full Text] [Related]
16. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y
JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084
[TBL] [Abstract][Full Text] [Related]
17. Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial.
Xie X; Jing J; Meng X; Claiborne Johnston S; Bath PM; Li Z; Zhao X; Liu L; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
Stroke; 2023 Sep; 54(9):2241-2250. PubMed ID: 37548009
[TBL] [Abstract][Full Text] [Related]
18. Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial.
Xie X; Jing J; Meng X; Johnston SC; Bath PM; Li Z; Zhao X; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
Stroke; 2024 Jul; 55(7):1739-1747. PubMed ID: 38860396
[TBL] [Abstract][Full Text] [Related]
19. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
[TBL] [Abstract][Full Text] [Related]
20. Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack.
Wang A; Meng X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang F; Wang Y; Huang P; Chen G; Wang Y;
Stroke; 2022 Sep; 53(9):2799-2808. PubMed ID: 35656824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]